Pharma-Bio Serv (PBSV) Current Assets (2016 - 2026)
Pharma-Bio Serv (PBSV) has disclosed Current Assets for 15 consecutive years, with $13.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Current Assets fell 14.73% year-over-year to $13.4 million, compared with a TTM value of $13.4 million through Oct 2025, down 14.73%, and an annual FY2025 reading of $13.4 million, down 14.73% over the prior year.
- Current Assets was $13.4 million for Q4 2025 at Pharma-Bio Serv, up from $13.2 million in the prior quarter.
- Across five years, Current Assets topped out at $28.9 million in Q1 2021 and bottomed at $13.2 million in Q3 2025.
- Average Current Assets over 5 years is $19.3 million, with a median of $19.3 million recorded in 2022.
- The sharpest move saw Current Assets grew 17.49% in 2021, then dropped 28.52% in 2022.
- Year by year, Current Assets stood at $22.8 million in 2021, then dropped by 12.61% to $19.9 million in 2022, then decreased by 2.72% to $19.4 million in 2023, then decreased by 19.08% to $15.7 million in 2024, then dropped by 14.73% to $13.4 million in 2025.
- Business Quant data shows Current Assets for PBSV at $13.4 million in Q4 2025, $13.2 million in Q3 2025, and $13.4 million in Q2 2025.